vs

Side-by-side financial comparison of Anterix Inc. (ATEX) and FEMASYS INC (FEMY). Click either name above to swap in a different company.

Anterix Inc. is the larger business by last-quarter revenue ($1.6M vs $813.4K, roughly 1.9× FEMASYS INC). Anterix Inc. runs the higher net margin — -419.6% vs -485.7%, a 66.0% gap on every dollar of revenue. On growth, FEMASYS INC posted the faster year-over-year revenue change (39.9% vs 0.4%). FEMASYS INC produced more free cash flow last quarter ($-4.3M vs $-8.3M). Over the past eight quarters, FEMASYS INC's revenue compounded faster (73.2% CAGR vs 11.7%).

Anterix Inc. is a U.S.-headquartered wireless communications company that owns licensed 900 MHz spectrum assets, providing secure, dedicated private broadband network solutions for critical infrastructure operators including electric utilities, public safety agencies, and transportation providers. Its primary market is North America, supporting clients requiring highly reliable connectivity for mission-critical operations.

Femasys Inc. is a medical technology firm specializing in developing and commercializing minimally invasive diagnostic and therapeutic devices for women's health. Its core products address unmet clinical needs in fertility care, gynecology and obstetrics, serving healthcare providers and patients mainly across North American and European markets.

ATEX vs FEMY — Head-to-Head

Bigger by revenue
ATEX
ATEX
1.9× larger
ATEX
$1.6M
$813.4K
FEMY
Growing faster (revenue YoY)
FEMY
FEMY
+39.4% gap
FEMY
39.9%
0.4%
ATEX
Higher net margin
ATEX
ATEX
66.0% more per $
ATEX
-419.6%
-485.7%
FEMY
More free cash flow
FEMY
FEMY
$4.0M more FCF
FEMY
$-4.3M
$-8.3M
ATEX
Faster 2-yr revenue CAGR
FEMY
FEMY
Annualised
FEMY
73.2%
11.7%
ATEX

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ATEX
ATEX
FEMY
FEMY
Revenue
$1.6M
$813.4K
Net Profit
$-6.6M
$-4.0M
Gross Margin
62.7%
Operating Margin
-576.0%
-568.3%
Net Margin
-419.6%
-485.7%
Revenue YoY
0.4%
39.9%
Net Profit YoY
-185.6%
22.9%
EPS (diluted)
$-0.35
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEX
ATEX
FEMY
FEMY
Q4 25
$1.6M
$813.4K
Q3 25
$1.6M
$729.4K
Q2 25
$1.4M
$409.3K
Q1 25
$1.4M
$341.3K
Q4 24
$1.6M
$581.6K
Q3 24
$1.6M
$554.9K
Q2 24
$1.5M
$221.5K
Q1 24
$1.3M
$271.1K
Net Profit
ATEX
ATEX
FEMY
FEMY
Q4 25
$-6.6M
$-4.0M
Q3 25
$53.5M
$-4.2M
Q2 25
$25.2M
$-4.6M
Q1 25
$9.2M
$-5.9M
Q4 24
$7.7M
$-5.1M
Q3 24
$-12.8M
$-5.4M
Q2 24
$-15.5M
$-4.7M
Q1 24
$-9.4M
$-3.6M
Gross Margin
ATEX
ATEX
FEMY
FEMY
Q4 25
62.7%
Q3 25
59.7%
Q2 25
61.4%
Q1 25
65.6%
Q4 24
66.9%
Q3 24
65.6%
Q2 24
67.0%
Q1 24
67.3%
Operating Margin
ATEX
ATEX
FEMY
FEMY
Q4 25
-576.0%
-568.3%
Q3 25
-500.9%
Q2 25
-941.1%
Q1 25
-1600.1%
Q4 24
-812.0%
Q3 24
-846.6%
-922.4%
Q2 24
-984.4%
-2023.7%
Q1 24
-834.2%
-1277.1%
Net Margin
ATEX
ATEX
FEMY
FEMY
Q4 25
-419.6%
-485.7%
Q3 25
3449.5%
-575.1%
Q2 25
1775.7%
-1120.5%
Q1 25
662.9%
-1727.9%
Q4 24
492.3%
-881.0%
Q3 24
-823.1%
-974.7%
Q2 24
-1018.0%
-2115.1%
Q1 24
-746.9%
-1327.5%
EPS (diluted)
ATEX
ATEX
FEMY
FEMY
Q4 25
$-0.35
$0.02
Q3 25
$2.86
$-0.10
Q2 25
$1.35
$-0.16
Q1 25
$0.51
$-0.23
Q4 24
$0.41
$-0.23
Q3 24
$-0.69
$-0.24
Q2 24
$-0.84
$-0.21
Q1 24
$-0.51
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEX
ATEX
FEMY
FEMY
Cash + ST InvestmentsLiquidity on hand
$29.5M
$9.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$236.0M
$5.9M
Total Assets
$417.0M
$20.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEX
ATEX
FEMY
FEMY
Q4 25
$29.5M
$9.3M
Q3 25
$39.1M
$4.6M
Q2 25
$41.4M
$3.2M
Q1 25
$47.4M
$3.8M
Q4 24
$28.8M
$3.5M
Q3 24
$43.1M
$7.6M
Q2 24
$51.7M
$13.5M
Q1 24
$60.6M
$17.8M
Stockholders' Equity
ATEX
ATEX
FEMY
FEMY
Q4 25
$236.0M
$5.9M
Q3 25
$240.3M
$4.6M
Q2 25
$184.8M
$1.5M
Q1 25
$156.6M
$2.0M
Q4 24
$144.7M
$2.3M
Q3 24
$139.1M
$6.0M
Q2 24
$148.8M
$11.3M
Q1 24
$161.0M
$15.6M
Total Assets
ATEX
ATEX
FEMY
FEMY
Q4 25
$417.0M
$20.7M
Q3 25
$420.4M
$16.3M
Q2 25
$359.6M
$13.8M
Q1 25
$333.1M
$13.3M
Q4 24
$326.7M
$12.4M
Q3 24
$317.2M
$15.6M
Q2 24
$321.1M
$20.3M
Q1 24
$324.9M
$24.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEX
ATEX
FEMY
FEMY
Operating Cash FlowLast quarter
$-8.3M
$-4.2M
Free Cash FlowOCF − Capex
$-8.3M
$-4.3M
FCF MarginFCF / Revenue
-526.4%
-531.7%
Capex IntensityCapex / Revenue
0.6%
17.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEX
ATEX
FEMY
FEMY
Q4 25
$-8.3M
$-4.2M
Q3 25
$1.4M
$-5.4M
Q2 25
$-3.1M
$-4.4M
Q1 25
$-16.6M
$-4.8M
Q4 24
$-7.7M
$-5.1M
Q3 24
$-2.6M
$-5.5M
Q2 24
$-2.4M
$-4.3M
Q1 24
$6.1M
$-4.6M
Free Cash Flow
ATEX
ATEX
FEMY
FEMY
Q4 25
$-8.3M
$-4.3M
Q3 25
$-5.6M
Q2 25
$-4.4M
Q1 25
$-16.6M
$-4.9M
Q4 24
$-5.2M
Q3 24
$-2.7M
$-5.9M
Q2 24
$-4.5M
Q1 24
$6.1M
$-4.6M
FCF Margin
ATEX
ATEX
FEMY
FEMY
Q4 25
-526.4%
-531.7%
Q3 25
-765.3%
Q2 25
-1086.6%
Q1 25
-1195.2%
-1424.7%
Q4 24
-890.9%
Q3 24
-173.4%
-1060.1%
Q2 24
-2035.8%
Q1 24
484.1%
-1708.6%
Capex Intensity
ATEX
ATEX
FEMY
FEMY
Q4 25
0.6%
17.2%
Q3 25
26.6%
Q2 25
23.0%
Q1 25
3.3%
28.3%
Q4 24
0.0%
18.4%
Q3 24
2.6%
73.5%
Q2 24
0.0%
82.4%
Q1 24
3.2%
23.8%
Cash Conversion
ATEX
ATEX
FEMY
FEMY
Q4 25
Q3 25
0.03×
Q2 25
-0.12×
Q1 25
-1.80×
Q4 24
-1.00×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons